NCT00833469View on ClinicalTrials.gov

Escitalopram (Lexapro) for the Treatment of Postpartum Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Postpartum Depression
Interventions
DRUG

Escitalopram

Once daily by mouth

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00833469 - Escitalopram (Lexapro) for the Treatment of Postpartum Depression | Biotech Hunter | Biotech Hunter